About the Authors

Maria Beconi

Affiliation CHDI Management/CHDI Foundation Inc., Los Angeles, California, United States of America

Omar Aziz

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Kim Matthews

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Lara Moumné

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

Catherine O’Connell

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Dawn Yates

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Steven Clifton

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Hannah Pett

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Julie Vann

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Lynsey Crowley

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Alan F. Haughan

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Donna L. Smith

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

Ben Woodman

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

Gillian P. Bates

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

Fred Brookfield

Affiliation Evotec (UK) Ltd., Abingdon, United Kingdom

Roland W. Bürli

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

George McAllister

Affiliation BioFocus, Saffron Walden, Essex, United Kingdom

Celia Dominguez

Affiliation CHDI Management/CHDI Foundation Inc., Los Angeles, California, United States of America

Ignacio Munoz-Sanjuan

Affiliation CHDI Management/CHDI Foundation Inc., Los Angeles, California, United States of America

Vahri Beaumont

vahri.beaumont@chdifoundation.org

Affiliation CHDI Management/CHDI Foundation Inc., Los Angeles, California, United States of America

Competing Interests

The authors have declared that no competing interests exist. CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington’s disease. Evotec (UK) and BioFocus (UK) conducted the research through a fee-for-service agreement for CHDI Foundation. This declaration does not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: MB OA KM LM DY GPB CD IMS RWB GM VB. Performed the experiments: OA KM LM COC SC HP JV LC AFH DLS BW FB. Analyzed the data: OA KM MB DY LM COC SC HP JV FB GPB VB. Contributed reagents/materials/analysis tools: FB. Wrote the paper: MB VB.